EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Proximal complement inhibition with pegcetacoplan in recurrent C3 glomerulopathy after pediatric kidney transplantation: a case report

Amit Eben Chaime, Hadas Alfandari, Ana Tobar Foigelman, Yael Borovitz

Pediatric Nephrology · 09.11.2026

DOI: 10.1007/s00467-026-07582-2 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pediatric Nephrology, online erschienen am 09.11.2026. Verfasst von Amit Eben Chaime und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Institute, Schneider Children's Medical Center, Petah Tikva, Israel. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

C3 glomerulopathy (C3G) is a rare complement-mediated kidney disease caused by dysregulation of the alternative pathway, often leading to progressive kidney failure and high post-transplant recurrence rates. Treatment options for recurrent disease are limited, though complement inhibitors have emerged as targeted therapies. A 9-year-old girl presented with edema, hypertension, hematuria, and low C3 levels. Kidney biopsy showed dense deposit disease. Despite corticosteroids and mycophenolate mofetil, she rapidly progressed to kidney failure requiring dialysis. After kidney transplantation, early recurrence occurred within 2 months. Treatment with renin–angiotensin system blockade and the C5 inhibitor ravulizumab led to transient improvement followed by relapse. Therapy was switched to pegcetacoplan. Early improvement was noticed within 2 weeks, and normal kidney function with no hematuria or proteinuria at 6 months. This case highlights the aggressive nature of pediatric C3G after kidney transplantation and suggests that proximal complement inhibition may improve disease control and graft outcomes.

Schlagwörter

Stichwörter der Autor:innen

C3GDDDPegcetacoplanPost-transplantation recurrence

Autor:innen und Institutionen

  • Nephrology Institute, Schneider Children's Medical Center, Petah Tikva, Israel.
  • Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Department of Pathology, Rabin Medical Center Beilinson Campus, Petah Tikva, Israel.
  • Nephrology Institute, Schneider Children's Medical Center, Petah Tikva, Israel. Yaelbo2@clalit.org.il.
  • Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Yaelbo2@clalit.org.il.

Zitieren

APA

Chaime, A. E., Alfandari, H., Foigelman, A. T., & Borovitz, Y. (2026). Proximal complement inhibition with pegcetacoplan in recurrent C3 glomerulopathy after pediatric kidney transplantation: a case report. Pediatric Nephrology. https://doi.org/10.1007/s00467-026-07582-2

Vancouver

Chaime AE, Alfandari H, Foigelman AT, Borovitz Y. Proximal complement inhibition with pegcetacoplan in recurrent C3 glomerulopathy after pediatric kidney transplantation: a case report. Pediatric Nephrology. 2026. doi:10.1007/s00467-026-07582-2

BibTeX
@article{Chaime2026,
  author = {Chaime, Amit Eben and Alfandari, Hadas and Foigelman, Ana Tobar and Borovitz, Yael},
  title = {Proximal complement inhibition with pegcetacoplan in recurrent C3 glomerulopathy after pediatric kidney transplantation: a case report},
  journal = {Pediatric Nephrology},
  year = {2026},
  doi = {10.1007/s00467-026-07582-2}
}
Kostenlos starten →